Seven Eight Capital, LP Axonics, Inc. Transaction History

Seven Eight Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$47.99 - $60.21 $375,761 - $471,444	7,830 New	7,830 $395,000
Q4 2021 Feb 14, 2022	SELL	$50.01 - $73.35 $185,987 - $272,788	-3,719 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$59.21 - $78.66 $220,201 - $292,536	3,719 New	3,719 $242,000
Q4 2020 Feb 09, 2021	SELL	$42.19 - $51.5 $1.27 Million - $1.55 Million	-30,139 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$35.33 - $51.04 $1.06 Million - $1.54 Million	30,139 New	30,139 $1.54 Million

5.03M

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.